Related Experiment Video
Updated: May 21, 2026
10:58
Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry
Published on: March 5, 2019
[Immunophenotype in multiple myeloma cells detected by multiparameter flow cytometry]
Fang-Fang Cao1, Fang Chen, Yan-Ping Hu
1Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|June 29, 2012
Summary
This study identified key immunophenotypic markers in multiple myeloma (MM) cells using flow cytometry. These findings aid in distinguishing MM cells from normal plasma cells for better targeted therapy and prognosis.
Area of Science:
- Hematology
- Immunology
- Oncology
Context:
- Multiple myeloma (MM) is a hematologic malignancy characterized by clonal plasma cells.
- Accurate immunophenotyping is crucial for MM diagnosis, prognosis, and treatment selection.
- Distinguishing MM cells from reactive plasmacytosis requires precise cellular marker analysis.
Purpose:
- To investigate the immunophenotypic characteristics of multiple myeloma cells.
- To evaluate the significance of these characteristics in differentiating MM from reactive plasmacytosis.
- To establish flow cytometry with CD38/SSC gating as a reliable method for MM cell detection.
Summary:
- Flow cytometry using CD38/SSC gating identified distinct immunophenotypic profiles in 33 MM cases compared to 12 reactive plasmacytosis controls.
- The typical MM immunophenotype was CD38(bright)CD138(+)CD19(-)CD56(+), observed in 78.8% of patients.
- Monoclonal restriction of kappa (cκ) or lambda (cλ) light chains was detected in 81.8% of MM cases.
Impact:
- The CD38/SSC gating method effectively discriminates myeloma cells from normal plasma cells.
- Immunophenotypic analysis provides critical evidence for guiding targeted therapy in multiple myeloma.
- These findings contribute to improved prognosis evaluation for patients with multiple myeloma.
